MidEuropa

Congratulations to our portfolio company FAMAR on achieving the EcoVadis Gold medal 🏅 This recognition places FAMAR among the top 5% of companies globally. We are proud to continue supporting FAMAR as they lead by example in delivering high-quality pharmaceutical solutions responsibly. #privateequity #sustainability

📣 Another landmark exit in MidEuropa's portfolio! We are thrilled to announce the sale of Regina Maria Group, Regina Maria, Reteaua de sanatate, a leading European private healthcare provider, to Mehiläinen, Finland's largest healthcare network. This transaction marks the largest ever healthcare services transaction in Central Europe. The company’s incredible growth journey, which resulted in an approximately ten-fold increase in the Group’s revenue and EBITDA since our original investment, reflects our proven playbook in healthcare services and across our other focus sectors. "We teamed up with and consistently backed the vision of a very entrepreneurial CEO, Fady Chreih, who developed a highly talented and driven management team. We executed on a strategy of in-market consolidation complemented by selective international expansion. Furthermore, we heavily invested in digitalisation to improve medical outcomes and patient experience, and to fully integrate the scaled-up business. We want to thank Fady and his team of managers and key physicians for their dedication and enthusiasm, and we wish them success as they work with Mehiläinen, their well-reputed management team, and experienced shareholders.” Matthew Strassberg, Partner and Head of the Healthcare sector at MidEuropa. Read more in our press release here: https://lnkd.in/d9E_kEuq #privateequity #healthcare #centraleurope

Two Partners of MidEuropa and senior executives from three of our healthcare portfolio companies were invited to present at Healthcare Business International conference in Paris earlier this week. We were delighted to share the insights on how we and our management teams collaborate to ensure that our portfolio companies consistently reach leadership positions in their sectors. ➡️ Matthew Strassberg, Partner and Head of Healthcare, joined Jakub Swadźba, the Founder and CEO of Diagnostyka, and Thibault Poirier of Rothschild & Co to share the unique factors behind the highly successful IPO of Diagnostyka earlier this year. ➡️ Paweł Malicki, Partner, joined Ana-Maria Pascu of Regina Maria, Reteaua de sanatate and Guillaume Duparc of L.E.K. Consulting to discuss how best to capitalise on the strong tailwinds supporting growth across healthcare services in Central Europe. ➡️ Fady Chreih, CEO of Regina Maria, Reteaua de sanatate, highlighted how the evolution towards patient-centric care delivery improves patient satisfaction and clinical outcomes. ➡️ Optegra Eye Health Care CEO Peter Byloos shared the key factors responsible for the growth, value creation, and efficiency at Optegra. In another panel, Optegra’s Dr Aleksandra (Ola) Spencer highlighted the improvements in patient satisfaction since the adoption of Iris, a state-of-the-art AI-driven virtual patient assistant. #privateequity #conference #healthcare #hbi2025

This week we celebrated International Women’s Day across our Warsaw, Bucharest, and London offices 💐 To mark this important occasion, we organised a clothes collection for charities supporting women re-entering the workforce.   This day is an opportunity to reflect on progress and reaffirm our commitment to gender diversity: ✅ Supporting women in our industry – We’ve proudly been members of Level 20 since 2016, a non-profit dedicated to improving gender diversity in private equity. This year, we’re putting forward our largest-ever cohort of mentors and mentees to their women’s mentorship programme. ✅ Enabling career progression – We recently reviewed and enhanced our parental leave policies to support women’s career growth and help close the gender pay gap. ✅ Driving meaningful change – We actively track diversity metrics across our portfolio companies and integrate meaningful initiatives to enhance talent management in our value creation plans.   We’re proud of the steps we’ve taken, and look forward to contributing to a more inclusive future. #privateequity #IWD2025 #InternationalWomensDay

"As an investor with a 25-year track record in the Central European region, one of our key strengths has been our ability to combine a pan-European perspective and network with strong local presence and credibility. This has been earned through decades of working on highly visible and successful investments." Matthew Strassberg, Partner and Head of Healthcare at MidEuropa, has been featured in a Q&A interview with Real Deals, where he discusses key favourable trends seen across Central Europe, as well as MidEuropa's recent activities, including the acquisition of FAMAR and the IPO of Diagnostyka. This last event raised €400 million in gross proceeds for MidEuropa and brought Diagnostyka's market capitalisation to above €1 billion. Click here to read the full article (subscription required): https://lnkd.in/dvuHyQt9 #centraleurope #privateequity #investment

📖 Our colleague Aleksandar Dragicevic recently spoke with Ziarul Financiar, Romania's leading business newspaper, on the country's strong economy and opportunities for private equity investment. Aleks reiterated MidEuropa's commitment to investing in Romania, whose economic growth is expected to exceed that of other European economies due to its rising household consumption and increasing purchasing power, as well as fast pace of innovation and technological advancement. Read more here: https://lnkd.in/dBkEuiMk

We are pleased to announce that MidEuropa-backed Diagnostyka, a leading provider of medical diagnostic services in Poland, has debuted on the Warsaw Stock Exchange (GPW). At the IPO share price of PLN 105, which was at the top of the price range, MidEuropa raised just over €400 million in gross proceeds for its investors.   Diagnostyka’s market capitalisation of above €1 billion on the day of the IPO ranks it as the second largest publicly listed healthcare services provider in Central Europe and among the top eight largest listed sector players in Europe.   We are extremely proud of what we have achieved together. During our ownership, the company completed over 120 acquisitions, achieved consistent revenue growth of 24% per annum, and increased the number of laboratory tests by a factor of eight.   We remain confident that Diagnostyka has a great future, and we wish the company, its CEO and co-founder, Jakub Swadźba, and the entire management team continued success. Read more here: https://lnkd.in/dKsY8pcA  #privateequity #centraleurope #healthcare

We are delighted to announce promotions of three of our colleagues, Paweł Malicki, Marek Rodak, and Filip Kisdobranski to Partners, in recognition of their achievements and contributions they make to the firm and within their teams. Congratulations! 👏 Read more about our 2025 Partner promotions in the article below: 👇 https://lnkd.in/d2negPvU

MidEuropa Principal Aleksandar Dragicevic shared his insights as a panellist at the Central & Eastern European Forum in Vienna earlier this month, hosted by Invisso (previously known as the Euromoney conference). The Forum provided a great opportunity to connect with local investors, entrepreneurs, banks, and advisers. Key topics discussed included: ➡️ the expected increase in Central European deal flow in 2025 on the back of stronger growth projections in the region, strongly outperforming the rest of Europe ➡️ growth trends in the technology and consumer sectors, such as the presence of a highly skilled IT labour force and the continuing shift in consumption preferences towards customised products and experiences ➡️ the increased connectivity of CE with the rest of Europe through cross-border investments and nearshoring of services #privateequity #centraleurope #conference #euromoney

We are excited to announce that MidEuropa has been shortlisted for the Private Equity House of the Year: Upper Mid-Cap for this year's Real Deals Private Equity Awards. This nomination reflects a strong year for MidEuropa in 2024, when we continued to draw on our 25-year experience in building industry champions out of Central Europe, originating new platform and bolt-on opportunities in the region, and creating value for all our stakeholders. Further details on the nominations can be found below 👇: https://lnkd.in/dWetVpuP #privateequity #privatemarkets #awards #midcap